SCHEMBL261258

SCHEMBL261258

CCCCC(C)(N=C=O)N=C=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367013 0.93 FDPS (0.34) FDPS
SCHEMBL7105549 0.91 GGPS1 (0.38) FDPS
SCHEMBL1696761 0.91 GGPS1 (0.38) FDPS
SCHEMBL635896 0.85 ALDH1A1 (0.31)
SCHEMBL11043523 0.81 FDPS (0.31) FDPS
SCHEMBL5478038 0.78 FDPS (0.32) FDPS
SCHEMBL8745312 0.77
SCHEMBL131478 0.77
SCHEMBL8951959 0.76 GGPS1 (0.31) FDPS
SCHEMBL12866831 0.76 GGPS1 (0.36) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114588939-B Catalyst and method for preparing iminooxadiazinedione-containing polyisocyanate 万华化学集团股份有限公司 2024-05-03 CN claimed
US-20240110002-A1 NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE INGEVITY UK LTD (GB) 2024-04-04 US claimed
WO-2024068129-A1 NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE INGEVITY UK LTD. (GB) 2024-04-04 WO claimed
CN-116041665-A Preparation method of isocyanate curing agent with high trimer content 南京工业大学 2023-05-02 CN claimed
CN-114588939-A Catalyst and process for preparing iminooxadiazinedione-containing polyisocyanates 万华化学集团股份有限公司 2022-06-07 CN claimed
EP-3263618-A1 ALKOXYSILANE FUNCTIONALIZED ALLOPHANATES Evonik Degussa GmbH (DE) 2018-01-03 EP claimed
EP-3263619-A1 ALKOXYSILANE AND ALLOPHANATE FUNCTIONALISED COATING AGENT Evonik Degussa GmbH (DE) 2018-01-03 EP claimed
EP-3263617-A1 ALKOXYSILANE- FUNCTIONALIZED AND ALLOPHANATE-FUNCTIONALIZED URETHANES Evonik Degussa GmbH (DE) 2018-01-03 EP claimed
EP-3263616-A1 ALKOXYSILANE FUNCTIONALIZED ALLOPHANATE-CONTAINING COATING AGENT Evonik Degussa GmbH (DE) 2018-01-03 EP claimed
EP-3055339-A1 POLYFUNCTIONAL URETHANE(METH)ACRYLATES CONSISTING OF LOW-MONOMER DIISOCYANATE MONOADDUCTS Evonik Degussa GmbH (DE) 2016-08-17 EP claimed
US-20070123642-A1 Phase change inks containing curable isocyanate-derived compounds XEROX CORPORATION 2007-05-31 US claimed
US-7067654-B2 Preparation of polyisocyanates containing uretdione groups BAYER MATERIALSCIENCE AG (DE) 2006-06-27 US claimed
EP-1179555-B1 1:1 Monoadducts from hydroxy(meth)acrylates and diisocyanates having low monomer content and process for their preparation DEGUSSA (DE) 2005-04-27 EP claimed
EP-1227895-B1 METHOD FOR PRODUCING BASE VARNISH/CLEAR VARNISH-TWO-COAT VARNISHES AND/OR TRANSPARENT SEALING LAYERS DU PONT (US) 2004-11-24 EP claimed
US-20040106789-A1 Preparation of polyisocyanates containing uretdione groups COVESTRO DEUTSCHLAND AG (DE) 2004-06-03 US claimed
US-6548696-B2 Useful as starting material for acrylic or isocyanate-functionalized crosslinker, a bonding agent for coatings and adhesives, and a linker for solid-phase synthesis of oligonucleotides, polynucleotides, or peptides DEGUSSA AG (DE) 2003-04-15 US claimed
EP-1227895-A2 METHOD FOR PRODUCING BASE VARNISH/CLEAR VARNISH-TWO-COAT VARNISHES AND/OR TRANSPARENT SEALING LAYERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-08-07 EP claimed
US-20020049349-A1 Low monomer 1:1-monoadducts from hydroxy (meth) acrylates and diisocyanates and a process for their manufacture DEGUSSA AG (DE) 2002-04-25 US claimed
EP-1179555-A1 1:1 Monoadducts from hydroxy(meth)acrylates and diisocyanates having low monomer content and process for their preparation Degussa AG (DE) 2002-02-13 EP claimed
WO-2001024946-A2 METHOD FOR PRODUCING BASE VARNISH/CLEAR VARNISH-TWO-COAT VARNISHES AND/OR TRANSPARENT SEALING LAYERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-04-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106789-A1 Preparation of polyisocyanates containing uretdione groups UROD, PUF60, UTS2R FDPS 236/4885
US-20020049349-A1 Low monomer 1:1-monoadducts from hydroxy (meth) acrylates and diisocyanates and a process for their manufacture NOS1, PAM, ACP1 FDPS 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.